12 Health Care Stocks Moving In Monday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Monday's pre-market session, several healthcare stocks experienced significant movements. Jin Medical International (ZJYL) led the gainers with a 19.2% increase, while MAIA Biotechnology (MAIA) saw the largest decline among the losers, dropping 19.1%. Other notable movers included Akso Health Group (AHG), CytoMed Therapeutics (GDTC), and NewAmsterdam Pharma (NAMS).
January 15, 2024 | 1:05 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Akso Health Group's stock rose by 17.97% to $1.05, with a market cap of $24.0 million.
The substantial pre-market rise indicates potential investor confidence, possibly leading to short-term price appreciation.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
CytoMed Therapeutics' shares increased by 14.78% to $4.97, with a market cap of $57.3 million.
The pre-market gain may attract more investors, potentially leading to a short-term positive impact on the stock price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Jin Medical International shares surged 19.2% in pre-market trading, with a market cap of $720.7 million.
The significant pre-market increase in share price suggests positive investor sentiment and could lead to a short-term uptrend.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
MAIA Biotechnology shares declined by 19.1% to $1.14, with a market cap of $19.3 million.
The sharp decline in pre-market trading could indicate negative news or investor sentiment, likely leading to a short-term downtrend.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
NEGATIVE IMPACT
NewAmsterdam Pharma stock fell 18.18% to $14.0, with a market cap of $1.1 billion.
The significant drop in pre-market could reflect investor concerns or negative developments, potentially leading to a short-term negative impact on the stock.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85